Pierre Fabre is the 2nd largest dermo-cosmetics laboratory in the world, the 2nd largest private French pharmaceutical group and the market leader in France for products sold over the counter in pharmacies.
Its portfolio includes several medical franchises and international brands including Pierre Fabre Oncologie, Pierre Fabre Dermatologie, Eau Thermale Avène, Klorane, Ducray, René Furterer, A-Derma, Naturactive, Pierre Fabre Oral Care.
Established in the Occitanie region since its creation, and manufacturing over 95% of its products in France, the Group employs some 10,000 people worldwide. Its products are distributed in about 130 countries. 86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan.
In 2019, Ecocert Environment assessed the Group’s corporate social and environmental responsibility approach in accordance with the ISO 26000 sustainable development standard and awarded it the “Excellence” level.
Pierre Fabre is recognized as one of the "World's Best Employers 2021" by Forbes. Our group is ranked in the Top 3 in the cosmetics industry and in the Top 10 in the pharmaceutical industry worldwide.
Your role within a pioneering and rapidly expanding company
GENERAL RESPONSIBILITIES
Under the responsibility of your manager, the Global Market Access Director, your main mission is to drive and help to develop pricing and reimbursement strategies for our products as well as manage subsequent activities (extensions, revision etc.), mainly in the oncology or rare disease area.
For products in (pre-/post-) launch, you:
- Define, in collaboration with the Market Access Director, the global market access strategy (pricing, reimbursement, launch sequence…),
- You actively participate in the construction and/or validation of deliverables constituting the global package and their updates in close collaboration with the HEOR representative,
- Regularly monitor activities with country Market Access representatives,
- Are identified as the Global Market Access representative to support countries in adapting pricing and reimbursement dossiers and are responsible for their validation before submission in accordance with internal processes,
- Anticipate objections and help country interlocutors respond to authorities' questions,
- Participate in Market Access evaluation of business cases for new country launch or when there is a need to reevaluate
- Supervise the work of consultants/ subcontractors, from the request for proposal to the provision of the deliverables, in terms of quality, timing and resources
For more mature products, you:
- Develop the strategy for maintaining pricing and reimbursement conditions and ensure its operational implementation,
- Conduct price impact/IRP analyses,
- Participate in the preparation of Pricing Committees.
Throughout the product lifecycle, you develop relationships with subsidiaries across the world (Europe, Asia, Africa, Middle East, USA) and franchises to identify needs and use the information obtained to benefit the development of pricing and reimbursement strategies.
You participate in the definition and monitoring of the budget within your scope.
You develop and maintain a robust understanding of relevant pricing and reimbursement criteria used by payers in key markets to make informed decisions about payer strategy, plans and tactics. You identify opportunities and challenges from a health policy, healthcare funding or governmental initiatives perspective.
Depending on priorities, you may be involved in cross-functional projects, Business Development (BD) assessments or work on early asset development (working on clinical development plans in order to anticipate requirements for pricing and reimbursement negotiations in countries of interest
and anticipating market access strategy)
Your skills at the service of innovative projects
- Educational Background: University degree in pharmacy, medicine, health
economics, public health, engineering or a related field;
- Senior position: over 7 years of experience in market access in the
pharmaceutical industry, an HTA organization or as a consultant with
experience of product launch, preferably in oncology and/or rare disease, in
key markets: experience of US or China market is a plus; Thorough
understanding of the payers/HTA environment
- Language: Fluent in English
- Project Management Expertise: Strong project management skills to oversee
multiple projects simultaneously, ensuring timely and successful delivery.
Ability to drive and influence strategic discussions.
- Behavioral: Ability to work with a multidisciplinary and multicultural team in
a matrix environment; an international culture is a must
- A high level of autonomy is essential
- Open minded and negotiation skills associated with excellent analytical skills.
- Strong project and process management skills, with the ability to handle
multiple priorities, manage complexity, and deliver on time and within budget.
- Location: hybrid, to be discussed
We are convinced that diversity is a source of fulfillment, social balance and complementarity for our employees, which is why our offers are open to all, without restriction.
What We Do
Pierre Fabre Group held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise.
This makes Pierre Fabre Group :
A pharmaceutical group with a strong positioning : medical and natural
The second largest dermo-cosmetics laboratory in the world
The second largest private French pharmaceutical group
The market leader in France for products sold over the counter in pharmacies.
Our portfolio includes several medical franchises and international brands including ;
Pharmaceutical Care
Pierre Fabre Oncologie
Pierre Fabre Dermatologie
Naturactive
Eau Thermale Avène
Klorane
Ducray
René Furterer
A-Derma
Pierre Fabre Oral Care
Glytone (US)
Darrow (Brasil)
Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France.
Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated €2.7 billion in revenues in 2022, 69% of which is from international business.
Pierre Fabre Group has a unique company structure.
86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan.
In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level : - Excellence being the highest maturity level of the ECOCERT 26000 standard








